Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.
CONCLUSIONS: Our study reflects the 'real world' experience in elderly RA patients on bDMARDs, with non-selected patients for a 14-year follow-up.
PMID: 28598787 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research
More News: Abatacept | Actemra | Arthritis | Drugs & Pharmacology | Enbrel | Humira | Orencia | Remicade | Rheumatoid Arthritis | Rheumatology | Rituxan | Study | Women